rs7217038
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2
The NM_001355573.2(CCDC92B):c.-24+1328A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00517 in 526,976 control chromosomes in the GnomAD database, including 62 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.014 ( 50 hom., cov: 32)
Exomes 𝑓: 0.0017 ( 12 hom. )
Consequence
CCDC92B
NM_001355573.2 intron
NM_001355573.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.401
Publications
4 publications found
Genes affected
CCDC92B (HGNC:52279): (coiled-coil domain containing 92B)
MIR1253 (HGNC:35318): (microRNA 1253) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0137 (2090/152240) while in subpopulation AFR AF = 0.0473 (1963/41536). AF 95% confidence interval is 0.0455. There are 50 homozygotes in GnomAd4. There are 927 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 50 gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CCDC92B | NM_001355573.2 | c.-24+1328A>T | intron_variant | Intron 1 of 3 | ENST00000614400.2 | NP_001342502.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CCDC92B | ENST00000614400.2 | c.-24+1328A>T | intron_variant | Intron 1 of 3 | 6 | NM_001355573.2 | ENSP00000509343.1 | |||
| MIR1253 | ENST00000408273.1 | n.100A>T | non_coding_transcript_exon_variant | Exon 1 of 1 | 6 | |||||
| hsa-mir-1253 | ENST00000609567.1 | n.6T>A | non_coding_transcript_exon_variant | Exon 1 of 1 | 6 |
Frequencies
GnomAD3 genomes AF: 0.0137 AC: 2087AN: 152122Hom.: 50 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
2087
AN:
152122
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00356 AC: 857AN: 240580 AF XY: 0.00275 show subpopulations
GnomAD2 exomes
AF:
AC:
857
AN:
240580
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00169 AC: 632AN: 374736Hom.: 12 Cov.: 0 AF XY: 0.00138 AC XY: 295AN XY: 214166 show subpopulations
GnomAD4 exome
AF:
AC:
632
AN:
374736
Hom.:
Cov.:
0
AF XY:
AC XY:
295
AN XY:
214166
show subpopulations
African (AFR)
AF:
AC:
470
AN:
10346
American (AMR)
AF:
AC:
105
AN:
35882
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
11678
East Asian (EAS)
AF:
AC:
0
AN:
13158
South Asian (SAS)
AF:
AC:
4
AN:
66606
European-Finnish (FIN)
AF:
AC:
1
AN:
26314
Middle Eastern (MID)
AF:
AC:
5
AN:
2758
European-Non Finnish (NFE)
AF:
AC:
15
AN:
191424
Other (OTH)
AF:
AC:
32
AN:
16570
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
33
65
98
130
163
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0137 AC: 2090AN: 152240Hom.: 50 Cov.: 32 AF XY: 0.0125 AC XY: 927AN XY: 74434 show subpopulations
GnomAD4 genome
AF:
AC:
2090
AN:
152240
Hom.:
Cov.:
32
AF XY:
AC XY:
927
AN XY:
74434
show subpopulations
African (AFR)
AF:
AC:
1963
AN:
41536
American (AMR)
AF:
AC:
95
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5168
South Asian (SAS)
AF:
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
11
AN:
68012
Other (OTH)
AF:
AC:
21
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
106
212
319
425
531
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
9
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.